Abstract
Osteoarthritis (OA) is a chronic joint disorder that causes cartilage degradation and subchondral bone abnormalities. Nangibotide, also known as LR12, is a dodecapeptide with considerable anti-inflammatory properties, but its significance in OA is uncertain. The aim of the study was to determine whether nangibotide could attenuate the progression of OA, and elucidate the underlying mechanism. In vitro experiments showed that nangibotide strongly inhibited TNF-α-induced osteogenic reduction, significantly enhanced osteoblast proliferation and prevented apoptosis in MC3T3-E1 cells. Male C57BL/6 J mice aged 2 months were randomly allocated to three groups: sham, ACLT, and ACLT with nangibotide therapy. Nangibotide suppressed ACLT-induced cartilage degradation and MMP-13 expression. MicroCT analysis revealed that nangibotide attenuated in vivo subchondral bone loss induced by ACLT. Histomorphometry results showed that nangibotide attenuated ACLT-induced osteoblast inhibition; TUNEL assays and immunohistochemical staining of cleaved-caspase3 further confirmed the in vivo anti-apoptotic effect of nangibotide on osteoblasts. Furthermore, we found that nangibotide exerted protective effects by suppressing TGF-β signaling mediated by Smad2/3 to restore coupled bone remodeling in the subchondral bone. In conclusion, the findings suggest that nangibotide might exert a protective effect on the bone-cartilage unit and maybe an alternative treatment option for OA.
Similar content being viewed by others
Data availability
All data included in this study are available from the corresponding author on reasonable request.
References
Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192. https://doi.org/10.1038/nm.3074
Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102:3324–3329. https://doi.org/10.1073/pnas.0408742102
Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, Lane TF, Krishnan V, Hankenson KD, MacDougald OA (2007) Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 22:1924–1932. https://doi.org/10.1359/jbmr.070810
Boer CG, Radjabzadeh D, Medina-Gomez C, Garmaeva S, Schiphof D, Arp P, Koet T, Kurilshikov A, Fu J, Ikram MA, Bierma-Zeinstra S, Uitterlinden AG, Kraaij R, Zhernakova A, van Meurs JBJ (2019) Intestinal microbiome composition and its relation to joint pain and inflammation. Nat Commun 10:4881. https://doi.org/10.1038/s41467-019-12873-4
Boufenzer A, Lemarié J, Simon T, Derive M, Bouazza Y, Tran N, Maskali F, Groubatch F, Bonnin P, Bastien C, Bruneval P, Marie PY, Cohen R, Danchin N, Silvestre JS, Ait-Oufella H, Gibot S (2015) TREM-1 Mediates inflammatory injury and cardiac remodeling following myocardial infarction. Circ Res 116:1772–1782. https://doi.org/10.1161/circresaha.116.305628
Butterfield NC, Curry KF, Steinberg J, Dewhurst H, Komla-Ebri D, Mannan NS, Adoum AT, Leitch VD, Logan JG, Waung JA, Ghirardello E, Southam L, Youlten SE, Wilkinson JM, McAninch EA, Vancollie VE, Kussy F, White JK, Lelliott CJ, Adams DJ, Jacques R, Bianco AC, Boyde A, Zeggini E, Croucher PI, Williams GR, Bassett JHD (2021) Accelerating functional gene discovery in osteoarthritis. Nat Commun 12:467. https://doi.org/10.1038/s41467-020-20761-5
Cao X (2011) Targeting osteoclast-osteoblast communication. Nat Med 17:1344–1346. https://doi.org/10.1038/nm.2499
Cuvier V, Lorch U, Witte S, Olivier A, Gibot S, Delor I, Garaud JJ, Derive M, Salcedo-Magguilli M (2018) A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition. Br J Clin Pharmacol 84:2270–2279. https://doi.org/10.1111/bcp.13668
Dallas SL, Prideaux M, Bonewald LF (2013) The osteocyte: an endocrine cell … and more. Endocr Rev 34:658–690. https://doi.org/10.1210/er.2012-1026
Derive M, Boufenzer A, Bouazza Y, Groubatch F, Alauzet C, Barraud D, Lozniewski A, Leroy P, Tran N, Gibot S (2013) Effects of a TREM-like transcript 1-derived peptide during hypodynamic septic shock in pigs. Shock 39:176–182. https://doi.org/10.1097/SHK.0b013e31827bcdfb
Derive M, Boufenzer A, Gibot S (2014) Attenuation of responses to endotoxin by the triggering receptor expressed on myeloid cells-1 inhibitor LR12 in nonhuman primate. Anesthesiology 120:935–942. https://doi.org/10.1097/aln.0000000000000078
Dubar M, Carrasco K, Gibot S, Bisson C (2018) Effects of Porphyromonas gingivalis LPS and LR12 peptide on TREM-1 expression by monocytes. J Clin Periodontol 45:799–805. https://doi.org/10.1111/jcpe.12925
François B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Pickkers P, Vandenhende F, Garaud JJ, Sánchez M, Salcedo-Magguilli M, Laterre PF (2020) Nangibotide in patients with septic shock: a phase 2a randomized controlled clinical trial. Intensive Care Med 46:1425–1437. https://doi.org/10.1007/s00134-020-06109-z
Francois B, Lambden S, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Grouin JM, Garaud JJ, Salcedo-Magguilli M, Levy M, Laterre PF (2021) Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. BMJ Open 11:e042921. https://doi.org/10.1136/bmjopen-2020-042921
Goldring SR (2009) Role of bone in osteoarthritis pathogenesis. Med Clin North Am 93:25–35. https://doi.org/10.1016/j.mcna.2008.09.006
Goldring SR (2012) Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis. Ther Adv Musculoskelet Dis 4:249–258. https://doi.org/10.1177/1759720x12437353
Goldring SR (2015) The osteocyte: key player in regulating bone turnover. RMD Open 1:e000049. https://doi.org/10.1136/rmdopen-2015-000049
Goldring MB, Goldring SR (2007) Osteoarthritis. J Cell Physiol 213:626–634. https://doi.org/10.1002/jcp.21258
Goldring SR, Goldring MB (2016) Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol 12:632–644. https://doi.org/10.1038/nrrheum.2016.148
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64:465–474. https://doi.org/10.1002/acr.21596
Houard X, Goldring MB, Berenbaum F (2013) Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep 15:375. https://doi.org/10.1007/s11926-013-0375-6
Jiang Y, Zhu L, Zhang T, Lu H, Wang C, Xue B, Xu X, Liu Y, Cai Z, Sang W, Hua Y, Ma J (2017) BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis. Biochim Biophys Acta Mol Basis Dis 1863:3001–3015. https://doi.org/10.1016/j.bbadis.2017.08.009
Jiao K, Zhang M, Niu L, Yu S, Zhen G, Xian L, Yu B, Yang K, Liu P, Cao X, Wang M (2014) Overexpressed TGF-β in subchondral bone leads to mandibular condyle degradation. J Dent Res 93:140–147. https://doi.org/10.1177/0022034513513034
Jolly L, Carrasco K, Derive M, Lemarié J, Boufenzer A, Gibot S (2018) Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Cardiovasc Res 114:907–918. https://doi.org/10.1093/cvr/cvy018
Kökten T, Gibot S, Lepage P, D’Alessio S, Hablot J, Ndiaye NC, Busby-Venner H, Monot C, Garnier B, Moulin D, Jouzeau JY, Hansmannel F, Danese S, Guéant JL, Muller S, Peyrin-Biroulet L (2018) TREM-1 Inhibition restores impaired autophagy activity and reduces colitis in Mice. J Crohns Colitis 12:230–244. https://doi.org/10.1093/ecco-jcc/jjx129
Kwon DG, Kim MK, Jeon YS, Nam YC, Park JS, Ryu DJ (2022) State of the art: the immunomodulatory role of MSCs for osteoarthritis. Int J Mol Sci 23:1618. https://doi.org/10.3390/ijms23031618
Liu T, Zhou Y, Li P, Duan JX, Liu YP, Sun GY, Wan L, Dong L, Fang X, Jiang JX, Guan CX (2016) Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Sci Rep 6:39473. https://doi.org/10.1038/srep39473
Lories RJ, Luyten FP (2011) The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7:43–49. https://doi.org/10.1038/nrrheum.2010.197
Maeda K, Takahashi N, Kobayashi Y (2013) Roles of Wnt signals in bone resorption during physiological and pathological states. J Mol Med (Berl) 91:15–23. https://doi.org/10.1007/s00109-012-0974-0
O’Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835–1841. https://doi.org/10.1210/en.2003-0990
O’Brien CA, Nakashima T, Takayanagi H (2013) Osteocyte control of osteoclastogenesis. Bone 54:258–263. https://doi.org/10.1016/j.bone.2012.08.121
Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, Sawa S, Nitta T, Takayanagi H (2017) Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol Rev 97:1295–1349. https://doi.org/10.1152/physrev.00036.2016
Prasadam I, Farnaghi S, Feng JQ, Gu W, Perry S, Crawford R, Xiao Y (2013) Impact of extracellular matrix derived from osteoarthritis subchondral bone osteoblasts on osteocytes: role of integrinβ1 and focal adhesion kinase signaling cues. Arthritis Res Ther 15:R150. https://doi.org/10.1186/ar4333
Rahmati M, Mobasheri A, Mozafari M (2016) Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone 85:81–90. https://doi.org/10.1016/j.bone.2016.01.019
Roos EM, Arden NK (2016) Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 12:92–101. https://doi.org/10.1038/nrrheum.2015.135
Sapir-Koren R, Livshits G (2014) Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int 25:2685–2700. https://doi.org/10.1007/s00198-014-2808-0
Shen J, Li S, Chen D (2014) TGF-β signaling and the development of osteoarthritis. Bone Res 2:14002. https://doi.org/10.1038/boneres.2014.2
Shi R, Zhang J, Peng Z, Yuan S, Gao S, Chen L, Yuan Y (2018) Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice. Int J Mol Med 41:2159–2168. https://doi.org/10.3892/ijmm.2018.3443
Tammaro A, Kers J, Emal D, Stroo I, Teske GJD, Butter LM, Claessen N, Damman J, Derive M, Navis GJ, Florquin S, Leemans JC, Dessing MC (2016) Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation. Sci Rep 6:38275. https://doi.org/10.1038/srep38275
Thankam FG, Sanchez DJ, Agrawal DK (2022) Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis. Mol Cell Biochem 477:701–710. https://doi.org/10.1007/s11010-021-04321-z
Thomas A, Eichenberger G, Kempton C, Pape D, York S, Decker AM, Kohia M (2009) Recommendations for the treatment of knee osteoarthritis, using various therapy techniques, based on categorizations of a literature review. J Geriatr Phys Ther 32:33–38. https://doi.org/10.1519/00139143-200932010-00007
Visweswaran M, Pohl S, Arfuso F, Newsholme P, Dilley R, Pervaiz S, Dharmarajan A (2015) Multi-lineage differentiation of mesenchymal stem cells—To Wnt, or not Wnt. Int J Biochem Cell Biol 68:139–147. https://doi.org/10.1016/j.biocel.2015.09.008
Wang Y, Xie X, Liu H, Liu H, Jiang H (2021) LR12 Promotes liver repair by improving the resolution of inflammation and liver regeneration in mice with thioacetamide- (TAA-) Induced acute liver failure. Mediators Inflamm 2021:2327721. https://doi.org/10.1155/2021/2327721
Yang HJ, Kim MJ, Qiu JY, Zhang T, Wu X, Jang DJ, Park S (2019) Rice porridge containing welsh onion root water extract alleviates osteoarthritis-related pain behaviors, glucose levels, and bone metabolism in osteoarthritis-induced ovariectomized rats. Nutrients 11:1503. https://doi.org/10.3390/nu11071503
Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, Carrino JA, Cosgarea A, Artemov D, Chen Q, Zhao Z, Zhou X, Riley L, Sponseller P, Wan M, Lu WW, Cao X (2013) Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704–712. https://doi.org/10.1038/nm.3143
Funding
This work was supported by the National Natural Science Foundation of China [grant numbers: 82172411, 81871795], Shanghai Municipal Health and Family Planning Commission [grant number: SHDC12017121] and Songjiang District Science and Technology Project [grant number: 18sjkjgg18].
Author information
Authors and Affiliations
Contributions
YZ and YX contributed to the experimental work and prepared the first draft of the paper. SX and LZ were responsible for the acquisition of the data. HL, CW and HC were responsible for the statistical analysis of the data. WS and JM designed the study and they are guarantors. All authors revised the paper critically for intellectual content and approved the final version. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
The study protocol has been approved by the Ethics Committee of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (#2020AWS0008, approved on March 23, 2020). All animal experiments conformed to the internationally accepted principles for the care and use of laboratory animals and approved by the Ethical Committee of the Shanghai General Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhong, Y., Xu, Y., Xue, S. et al. Nangibotide attenuates osteoarthritis by inhibiting osteoblast apoptosis and TGF-β activity in subchondral bone. Inflammopharmacol 30, 1107–1117 (2022). https://doi.org/10.1007/s10787-022-00984-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-022-00984-2